Skip to main content

Miami Cancer Institute

See Also:
Expert Gallery Profiles
MCI Research Associate Program

Submissions from 2025 2025

Multidisciplinary management strategies for recurrent brain metastasis after prior radiotherapy: An overview, Rupesh Kotecha and Alonso La Rosa

Clinical and Genetic Markers of Vascular Toxicity in Glioblastoma Patients: Insights from NRG Oncology RTOG-0825, Minesh Mehta

Consortium for Intracranial Metastasis Academic Research (CIMARa): Global interdisciplinary collaborations to improve outcomes of patient with brain metastases, Manmeet Ahluwalia

Trends and outcomes of heart failure hospitalizations during COVID-19 pandemic, Muni Rubens, Venkataraghavan Ramamoorthy, Anshul Saxena, Atulya Khosla, Peter McGranaghan, Yanjia Zhang, Sandra Chaparro, and Javier Jimenez

Complexity and Experience Grading to Guide Patient Selection for Minimally-invasive Pancreatoduodenectomy: An ISGPS Consensus, Horacio Asbun

Economic Model of Uridine Triacetate Versus Supportive Care for the Treatment of Patients with Life-Threatening Early-Onset Severe Toxicity, Jorge Garcia

Impact of Social Determinants of Health on Cancer Treatment Referrals in Patients Living with HIV in the United States: A Narrative Review, Marco Ruiz Andia and Jannelle Vicens

Oral mucosal toxicities in oncology, Alessandro Villa

Osseous Maxillary Reconstruction with Immediate Dental Implant Placement: An Optimized Workflow for the Oncologic Patient, Evan Rosen

Quality of Cancer Recurrence Data in the National Cancer Database: A Reappraisal of Reporting Readiness, Vicki Hawhee and Karen Mason

Stereotactic Body Radiotherapy for liver metastases: Systematic review and meta-analysis with International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines, Rupesh Kotecha and Zhenwei Zhang

Weight loss, nutritional aspects and quality of life in head and neck cancer survivors, Alessandro Villa

Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma, Rupesh Kotecha

Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer, Rupesh Kotecha

CASE (CemiplimAb-rwlc Survivorship and Epidemiology): a study in advanced basal cell carcinoma, Guilherme Rabinowits

Evaluation of Human Papillomavirus Vaccination and Cancer Prevention Behaviors among LGBTQI + Individuals: A Cross-Sectional Study, Alessandro Villa

Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions, Manmeet Ahluwalia

Leptomeningeal metastatic disease: new frontiers and future directions, Manmeet Ahluwalia

Stereotactic Radiosurgery for Intermediate (III) or High (IV-V) Spetzler-Martin Grade Arteriovenous Malformations: International Stereotactic Radiosurgery Society Practice Guideline, Rupesh Kotecha

Use of computer-assisted hexapod external fixators for complex foot and ankle reconstructions - An analysis of functional outcomes and complications, Juan Pretell

Mycobacterium immunogenum-Induced Thrombocytopenia, Sandra Sepulveda and Marco Ruiz-Andia

Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era, Camila Masias

Oncological Outcomes of Patients With Oral Potentially Malignant Disorders, Alessandro Villa

Principles of Surgical Treatment of Soft Tissue Sarcomas, Juan Pretell

Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma, Yuliya Linhares